CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BridgeBio Oncology Therapeutics, Inc.
Sign in to watch- Ticker
- BBOT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857 702 0377
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Helix Acquisition Corp. II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −203 | $2.68 | $544 | 13,812 |
| 2026-10-01 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −126 | $3.94 | $496 | 14,015 |
| 2026-10-01 | Elmelech Idan COO & Principal Financial Ofcr | Shares withheld for taxes | −343 | $3.94 | $1K | 14,152 |
| 2026-10-01 | Beltran Pedro President and CEO | Shares withheld for taxes | −1,047 | $3.94 | $4K | 43,529 |
| 2026-10-01 | Ben Yong Chief Med & Dev Officer | Shares withheld for taxes | −1,047 | $3.94 | $4K | 43,529 |
| 2026-09-10 | Cobo Marc Principal Accounting Officer | Grant or award | +9,038 | 14,344 | ||
| 2026-09-10 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −203 | $5.52 | $1K | 14,141 |
| 2026-09-10 | Cobo Marc Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +43,700 | 43,700 | ||
| 2026-07-01 | Chen Bihua Director | Other disposition | −4,528,186 | 0 | ||
| 2026-07-01 | Chen Bihua Director | Other acquisition | +2,692,459 | 4,879,995 | ||
| 2026-07-01 | Chen Bihua Director | Other acquisition | +1,704,862 | 5,010,332 | ||
| 2026-07-01 | Chen Bihua Director | Other acquisition | +130,865 | 6,083,221 | ||
| 2026-07-01 | Cobo Marc Principal Accounting Officer | Shares withheld for taxes | −125 | $7.80 | $975 | 5,306 |
| 2026-07-01 | Elmelech Idan COO & Principal Financial Ofcr | Shares withheld for taxes | −343 | $7.80 | $3K | 14,495 |
| 2026-07-01 | Ben Yong Chief Med & Dev Officer | Shares withheld for taxes | −1,047 | $7.80 | $8K | 44,576 |
| 2026-07-01 | Beltran Pedro President and CEO | Shares withheld for taxes | −1,047 | $7.80 | $8K | 44,576 |
| 2026-06-16 | Tipirneni Praveen P. Director | Grant or award · Stock Option (Right to Buy) | +31,675 | 31,675 | ||
| 2026-06-16 | MCCORMICK FRANK Director | Grant or award · Stock Option (Right to Buy) | +31,675 | 31,675 | ||
| 2026-06-16 | Lebowitz Peter F Director | Grant or award · Stock Option (Right to Buy) | +7,289 | 7,289 | ||
| 2026-06-16 | Kelleher Raymond J. Director | Grant or award · Stock Option (Right to Buy) | +31,675 | 31,675 |
Page 1 of 4 · 69 trades